Complete financial analysis of McKesson Corporation (0JZU.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Corporation, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- LG Uplus Corp. (032640.KS) Income Statement Analysis – Financial Results
- Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) Income Statement Analysis – Financial Results
- Corby Spirit and Wine Limited (CBYDF) Income Statement Analysis – Financial Results
- Ascent Industries Co. (ACNT) Income Statement Analysis – Financial Results
- Sterling Bancorp, Inc. (Southfield, MI) (SBT) Income Statement Analysis – Financial Results
McKesson Corporation (0JZU.L)
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.05B | 137.39B | 122.20B |
| Cost of Revenue | 296.37B | 264.84B | 251.32B | 226.65B | 219.65B | 203.56B | 197.97B | 187.85B | 179.94B | 167.63B | 128.95B | 115.31B |
| Gross Profit | 12.58B | 11.87B | 12.65B | 11.58B | 11.40B | 10.76B | 10.39B | 10.69B | 10.94B | 11.41B | 8.44B | 6.89B |
| Gross Profit Ratio | 4.07% | 4.29% | 4.79% | 4.86% | 4.93% | 5.02% | 4.99% | 5.38% | 5.73% | 6.37% | 6.14% | 5.64% |
| Research & Development | 179.00M | 89.00M | 70.00M | 74.00M | 96.00M | 71.00M | 125.00M | 341.00M | 392.00M | 392.00M | 457.00M | 433.00M |
| General & Administrative | 6.91B | 6.58B | 9.44B | 7.85B | 8.18B | 7.49B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.10B | 1.20B | 1.10B | 1.00B | 1.00B | 951.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.01B | 7.33B | 9.86B | 8.00B | 8.29B | 7.61B | 7.35B | 6.99B | 6.70B | 7.90B | 5.39B | 4.11B |
| Other Expenses | 486.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.68B | 7.42B | 9.93B | 8.07B | 8.39B | 7.68B | 7.47B | 7.33B | 7.09B | 8.40B | 5.98B | 4.72B |
| Cost & Expenses | 305.04B | 272.26B | 261.24B | 234.72B | 228.04B | 211.24B | 205.44B | 195.18B | 187.03B | 176.03B | 134.94B | 120.03B |
| Interest Income | 0.00 | 107.00M | 10.00M | 12.00M | 49.00M | 39.00M | 235.00M | 279.00M | 335.00M | 354.00M | 284.00M | 218.00M |
| Interest Expense | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 635.00M | 857.00M | 1.00B | 1.22B | 922.00M | 949.00M | 951.00M | 910.00M | 885.00M | 1.02B | 685.00M | 525.00M |
| EBITDA | 4.67B | 5.74B | 3.11B | -3.60B | 2.32B | 4.06B | 3.86B | 4.39B | 4.56B | 4.14B | 3.06B | 2.74B |
| EBITDA Ratio | 1.51% | 1.92% | 1.41% | 1.99% | 1.70% | 1.88% | 1.86% | 2.15% | 2.48% | 2.31% | 2.39% | 2.35% |
| Operating Income | 3.91B | 4.45B | 2.72B | 3.51B | 3.01B | 3.08B | 2.92B | 3.36B | 3.85B | 3.12B | 2.59B | 2.35B |
| Operating Income Ratio | 1.27% | 1.61% | 1.03% | 1.47% | 1.30% | 1.44% | 1.40% | 1.69% | 2.02% | 1.74% | 1.89% | 1.92% |
| Total Other Income/Expenses | -120.00M | 177.00M | -795.00M | 6.00M | -1.87B | -2.47B | -2.68B | -231.00M | -601.00M | -311.00M | -423.00M | -398.00M |
| Income Before Tax | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B | 3.25B | 2.66B | 2.17B | 1.95B |
| Income Before Tax Ratio | 1.23% | 1.67% | 0.73% | -2.11% | 0.50% | 0.28% | 0.11% | 3.47% | 1.70% | 1.48% | 1.58% | 1.60% |
| Income Tax Expense | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B | 908.00M | 815.00M | 757.00M | 587.00M |
| Net Income | 3.00B | 3.56B | 1.11B | -4.54B | 900.00M | 34.00M | 67.00M | 5.18B | 2.26B | 1.78B | 1.42B | 1.36B |
| Net Income Ratio | 0.97% | 1.29% | 0.42% | -1.91% | 0.39% | 0.02% | 0.03% | 2.61% | 1.18% | 0.99% | 1.03% | 1.12% |
| EPS | 22.54 | 25.23 | 7.31 | -28.26 | 4.97 | 0.17 | 0.32 | 23.45 | 9.82 | 7.54 | 6.08 | 5.69 |
| EPS Diluted | 22.39 | 25.04 | 7.23 | -28.26 | 4.95 | 0.17 | 0.32 | 23.24 | 9.69 | 7.55 | 6.09 | 5.70 |
| Weighted Avg Shares Out | 133.20M | 141.10M | 152.30M | 160.60M | 181.00M | 196.00M | 208.00M | 221.00M | 230.00M | 235.41M | 233.39M | 239.54M |
| Weighted Avg Shares Out (Dil) | 134.10M | 142.20M | 154.10M | 160.60M | 182.00M | 197.00M | 209.00M | 223.00M | 233.00M | 235.00M | 233.00M | 239.00M |
Source: https://incomestatements.info
Category: Stock Reports